Shengwen Cheng, Senrui Liu, Bowen Chen, Chengcheng Du, Pengcheng Xiao, Xuefeng Luo, . . . Wei Huang. (2023). Psoralidin inhibits osteosarcoma growth and metastasis by downregulating ITGB1 expression via the FAK and PI3K/Akt signaling pathways. BMC.
Chicago Style (17th ed.) CitationShengwen Cheng, et al. Psoralidin Inhibits Osteosarcoma Growth and Metastasis by Downregulating ITGB1 Expression via the FAK and PI3K/Akt Signaling Pathways. BMC, 2023.
MLA (9th ed.) CitationShengwen Cheng, et al. Psoralidin Inhibits Osteosarcoma Growth and Metastasis by Downregulating ITGB1 Expression via the FAK and PI3K/Akt Signaling Pathways. BMC, 2023.
Warning: These citations may not always be 100% accurate.